Field & Main Bank Amgen Inc Transaction History

Field & Main Bank

$278 Million
Q3 2024

A detailed history of Field & Main Bank transactions in Amgen Inc stock. As of the latest transaction made, Field & Main Bank holds 7,248 shares of AMGN stock, worth $2.31 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

7,248

Previous 7,428 2.42%

Holding current value

$2.31 Million

Previous $2.32 Million 0.65%

% of portfolio

0.84%

Previous 0.88%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$309.38 - $337.38 $55,688 - $60,728	-180 Reduced 2.42%	7,248 $2.34 Million
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $9,196 - $11,175	-35 Reduced 0.47%	7,428 $2.32 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $18,820 - $22,719	70 Added 0.95%	7,463 $2.12 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $11,506 - $12,980	45 Added 0.61%	7,393 $2.13 Million
Q3 2023 Oct 12, 2023	BUY	$218.65 - $271.46 $610,033 - $757,373	2,790 Added 61.21%	7,348 $1.97 Million
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $12,213 - $14,442	-57 Reduced 1.24%	4,558 $1.01 Million
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $42,222 - $51,462	187 Added 4.22%	4,615 $1.12 Million
Q4 2022 Jan 19, 2023	SELL	$229.03 - $291.01 $14,428 - $18,333	-63 Reduced 1.4%	4,428 $0
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $19,976 - $22,530	-89 Reduced 1.94%	4,491 $1.01 Million
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $6,459 - $7,188	-28 Reduced 0.61%	4,580 $1.11 Million
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $1,096 - $1,212	5 Added 0.11%	4,608 $1.11 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $7,955 - $9,104	40 Added 0.88%	4,603 $1.04 Million
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $64,742 - $75,853	-305 Reduced 6.27%	4,563 $970,000
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $75,913 - $84,220	325 Added 7.15%	4,868 $1.19 Million
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $5,547 - $6,465	25 Added 0.55%	4,543 $1.13 Million
Q4 2020 Feb 25, 2021	SELL	$216.38 - $257.67 $51,931 - $61,840	-240 Reduced 5.04%	4,518 $1.04 Million
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $18,772 - $20,876	-80 Reduced 1.65%	4,758 $1.21 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $989 - $1,213	-5 Reduced 0.1%	4,838 $1.14 Million
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $8,514 - $10,944	45 Added 0.94%	4,843 $1.17 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $27,857 - $33,379	160 Added 3.45%	4,798 $928,000
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $14,169 - $16,609	85 Added 1.87%	4,638 $855,000
Q1 2019 Apr 24, 2019	BUY	$180.87 - $203.88 $19,895 - $22,426	110 Added 2.48%	4,553 $865,000
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $20,381 - $22,977	110 Added 2.54%	4,443 $921,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $29,889 - $33,571	180 Added 4.33%	4,333 $852,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $58,453 - $68,310	345 Added 9.06%	4,153 $0
Q4 2017 Jan 24, 2018	BUY	$168.79 - $188.59 $642,752 - $718,150	3,808	3,808 $662,000

Others Institutions Holding AMGN

# of Institutions

3,090

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.

Account